| Genome-wide polygenic scores for common diseases identify individuals with risk equivalent to monogenic mutations AV Khera, M Chaffin, KG Aragam, ME Haas, C Roselli, SH Choi, ... Nature genetics 50 (9), 1219, 2018 | 2514 | 2018 |
| Multiancestry genome-wide association study of 520,000 subjects identifies 32 loci associated with stroke and stroke subtypes R Malik, G Chauhan, M Traylor, M Sargurupremraj, Y Okada, A Mishra, ... Nature genetics 50 (4), 524, 2018 | 1236 | 2018 |
| Multi-ethnic genome-wide association study for atrial fibrillation C Roselli, MD Chaffin, LC Weng, S Aeschbacher, G Ahlberg, CM Albert, ... Nature genetics 50 (9), 1225, 2018 | 604 | 2018 |
| Genome-wide association and Mendelian randomisation analysis provide insights into the pathogenesis of heart failure S Shah, A Henry, C Roselli, H Lin, G Sveinbjörnsson, G Fatemifar, ... Nature Communications 11 (1), 1-12, 2020 | 531 | 2020 |
| A genetic variant associated with five vascular diseases is a distal regulator of endothelin-1 gene expression RM Gupta, J Hadaya, A Trehan, SM Zekavat, C Roselli, D Klarin, ... Cell 170 (3), 522-533. e15, 2017 | 404 | 2017 |
| Transcriptional and cellular diversity of the human heart NR Tucker, M Chaffin, SJ Fleming, AW Hall, VA Parsons, KC Bedi Jr, ... Circulation 142 (5), 466-482, 2020 | 354 | 2020 |
| Large-scale analyses of common and rare variants identify 12 new loci associated with atrial fibrillation IE Christophersen, M Rienstra, C Roselli, X Yin, B Geelhoed, J Barnard, ... Nature genetics 49 (6), 946, 2017 | 316 | 2017 |
| Whole-genome sequencing to characterize monogenic and polygenic contributions in patients hospitalized with early-onset myocardial infarction AV Khera, M Chaffin, SM Zekavat, RL Collins, C Roselli, P Natarajan, ... Circulation 139 (13), 1593-1602, 2019 | 241 | 2019 |
| Discovery and systematic characterization of risk variants and genes for coronary artery disease in over a million participants KG Aragam, T Jiang, A Goel, S Kanoni, BN Wolford, DS Atri, EM Weeks, ... Nature Genetics, 1-13, 2022 | 207 | 2022 |
| Predicting benefit from evolocumab therapy in patients with atherosclerotic disease using a genetic risk score: results from the FOURIER trial NA Marston, FK Kamanu, F Nordio, Y Gurmu, C Roselli, PS Sever, ... Circulation 141 (8), 616-623, 2020 | 160 | 2020 |
| Association Between Titin Loss-of-Function Variants and Early-Onset Atrial Fibrillation SH Choi, LC Weng, C Roselli, H Lin, CM Haggerty, MB Shoemaker, ... Jama 320 (22), 2354-2364, 2018 | 152 | 2018 |
| Genetics of atrial fibrillation in 2020: GWAS, genome sequencing, polygenic risk, and beyond C Roselli, M Rienstra, PT Ellinor Circulation Research 127 (1), 21-33, 2020 | 140 | 2020 |
| Deep learning enables genetic analysis of the human thoracic aorta JP Pirruccello, MD Chaffin, EL Chou, SJ Fleming, H Lin, M Nekoui, ... Nature Genetics, 1-12, 2021 | 115 | 2021 |
| Sleep timing is more important than sleep length or quality for medical school performance L Genzel, K Ahrberg, C Roselli, S Niedermaier, A Steiger, M Dresler, ... Chronobiology international 30 (6), 766-771, 2013 | 111 | 2013 |
| Genetic Risk Prediction of Atrial Fibrillation SA Lubitz, X Yin, HJ Lin, M Kolek, JG Smith, S Trompet, M Rienstra, ... Circulation 135 (14), 1311-1320, 2017 | 105 | 2017 |
| Monogenic and Polygenic Contributions to Atrial Fibrillation Risk: Results From a National Biobank SH Choi, SJ Jurgens, LC Weng, JP Pirruccello, C Roselli, M Chaffin, ... Circulation Research 126 (2), 200-209, 2020 | 85 | 2020 |
| Heritability of Atrial Fibrillation LC Weng, SH Choi, D Klarin, JG Smith, PR Loh, M Chaffin, C Roselli, ... Circulation: Genomic and Precision Medicine 10 (6), e001838, 2017 | 85 | 2017 |
| Analysis of rare genetic variation underlying cardiometabolic diseases and traits among 200,000 individuals in the UK Biobank SJ Jurgens, SH Choi, VN Morrill, M Chaffin, JP Pirruccello, JL Halford, ... Nature Genetics, 1-11, 2022 | 84 | 2022 |
| Assessment of the relationship between genetic determinants of thyroid function and atrial fibrillation: a mendelian randomization study C Ellervik, C Roselli, IE Christophersen, A Alonso, M Pietzner, CM Sitlani, ... JAMA cardiology 4 (2), 144-152, 2019 | 80 | 2019 |
| The Effect of PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9) Inhibition on the Risk of Venous Thromboembolism NA Marston, Y Gurmu, GEM Melloni, M Bonaca, B Gencer, PS Sever, ... Circulation 141 (20), 1600-1607, 2020 | 75 | 2020 |
Patrick T. Ellinor, MD, PhDBroad Institute of MIT and Harvard, Massachusetts General Hospital, Harvard Medical SchoolVerified email at mgh.harvard.edu
